News

Wells Fargo Boosts Price Target for SAIC Amid Strong Performance

Wells Fargo Boosts Price Target for SAIC Amid Strong Performance

Wells Fargo Adjusts Price Target for Science Applications

Wells Fargo has recently made headlines by adjusting its price target for Science Applications International Corporation (NASDAQ: SAIC). The new price target stands at $157, an increase from the previous target of $122. This revision follows the company’s impressive second-quarter performance as well as an uptick in share repurchases.

The analyst from Wells Fargo assigned the new price target based on a multiple of 17.5 applied to projected earnings per share (EPS) for fiscal year 2026. This approach aligns with the current trading value of Science Applications, reflecting confidence in its earnings potential. Additionally, Wells Fargo has updated its EPS forecast for fiscal year 2025 to $8.12, which is an increase from $8.01, attributed to the company’s strong earnings last quarter and active share repurchase program.

There’s also been a positive adjustment in the tax rate forecast for fiscal year 2026, where a 22% rate is expected, showing a small decrease from the previously predicted 23%. This updated forecast was developed to consider the tax aspects in conjunction with growth projected from the solid base established in fiscal year 2025.

The recent increase in price target showcases Wells Fargo’s confidence in Science Applications’ financial resilience and the anticipated upward trajectory of the company. The update reflects both the recent strong performance and the expected advantages derived from continued share buybacks and a consistent tax environment.

Moreover, other notable developments surrounding SAIC indicate the company's upward momentum. Recently, JPMorgan upgraded the stock from Neutral to Overweight, also increasing its price target to $170. This impressive upgrade results from the company’s successful shift toward higher-value projects and a significant increase in submitted bids from $17 billion last year to $22 billion this year.

In a significant development, SAIC was awarded a $229 million contract by the U.S. Department of Defense aimed at enhancing the IT capabilities of NORAD and USNORTHCOM. Moreover, they reported a 2% increase in revenue for the second fiscal quarter, complemented by a slight 2% fall in EBITDA, overshadowed by an optimistic fiscal outlook projecting 3% revenue growth and 4% EBITDA growth for the fiscal year 2025.

Positive Market Sentiment and Strategic Developments

Analysts at Jefferies have also raised their stock target for SAIC from $140.00 to $148.00, while maintaining a hold rating. This nearly uniform upgrade from various financial institutions underscores the ongoing strategic transition SAIC is undertaking toward targeted growth and enhanced bidding processes. They have expressed a goal of achieving a book-to-bill ratio of 1.2 by the first half of fiscal year 2026 while pursuing 5% organic revenue growth by the end of that fiscal year.

As the landscape of defense contracting and IT services evolves, Science Applications has adeptly positioned itself to take advantage of rising opportunities in high-demand areas of service. By focusing on competitive bidding and enhancing capabilities, they’ve shown commitment to sustainable growth and shareholder value.

Market Performance and Investor Confidence

Science Applications International Corporation has maintained a strong market presence, reflecting positively in its valuation and stock price performance. Current market data reveals that SAIC holds a market capitalization of approximately $7.07 billion and a P/E ratio of 25.88, demonstrating investor confidence in the company's earning potential.

Share buybacks have become a significant part of SAIC’s strategy, reinforcing Wells Fargo's insights regarding increased repurchase activities which often signal strong management belief in the company's valuation. This proactive approach can directly contribute to enhanced earnings per share. Furthermore, SAIC has consistently upheld its dividend payments for over a decade, highlighting its committed stance toward shareholder returns.

With the company's stock currently trading near its 52-week high, the upward momentum with a return of 23.03% in the past three months further supports the rationale behind Wells Fargo's revised price target.

Conclusion and Future Outlook

Science Applications continues to thrive in a competitive environment with robust financial results and strong market strategies. The adjustments from major financial institutions mirror their dedication to delivering valuable services and growth in their contracts. As they progress further into fiscal year 2026, maintaining focus on high-value projects and strategic objectives will be essential for sustaining this positive trajectory.

Frequently Asked Questions

What is the new price target set by Wells Fargo for SAIC?

The new price target set by Wells Fargo for Science Applications International Corporation (SAIC) is $157.

Why did Wells Fargo increase the price target for SAIC?

The increase was driven by stronger-than-expected quarterly performance and an uptick in share repurchases.

Who else has recently updated their outlook for SAIC?

JPMorgan upgraded SAIC from Neutral to Overweight with a price target of $170, citing a shift toward higher-value projects.

What recent contract has SAIC secured?

SAIC secured a $229 million contract from the U.S. Department of Defense to enhance IT capabilities.

What is the company's financial strategy moving forward?

SAIC aims for a book-to-bill ratio of 1.2 by the first half of fiscal year 2026 and a 5% organic revenue growth by the end of the same year.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Chemours Faces Class Action Over Fraud Allegations

Updated Category News Views 206

Chemours and the Aftermarket Mirage When it rains, it pours, and for Chemours, the forecast isn't looking sunny. Investors are gearing up to slap Chemours Company (NYSE: CC) with a securities fraud class action. Why, you ask? Overstatement of aftermarket demand for refrigerants left investors high and dry after stock prices took an 18% nosedive. On August 4, 2026,...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 112

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 146

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 63

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
Lunit, Summit Tackle Tumor Analysis with AI Platform

Updated Category News Views 212

Amid whispers of AI revolutionizing every industry, let's zero in on its latest pit stop—oncology R&D. Lunit, shaking hands with Summit Therapeutics, plans to bring artificial intelligence into the tumor microenvironment analysis game, thanks to the Lunit SCOPE IO platform. This isn't just another lab experiment; it's a step towards redefining how we understand cancer's...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 66

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 35

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 46

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 27

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 89

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading

Top 5 Most Recently Viewed Articles

Fresh Del Monte's Sustainability Report Shows Significant Progress

Updated Category News Views 200

Fresh Del Monte's 2023 Sustainability Goals Fresh Del Monte Produce Inc. (NYSE: FDP), a prominent player in the global fruit and vegetable market, has released its sustainability report for the year, highlighting a remarkable journey toward environmental stewardship. This report showcases the substantial progress Fresh Del Monte has made in its sustainability initiatives,...

Continue Reading
MEXC Enhances User Security with New Compliance Measures

Updated Category News Views 118

MEXC Enhances User Security with New Compliance Measures MEXC, a prominent cryptocurrency exchange renowned for its global reach, has taken significant steps to enhance risk control and compliance protocols aimed at safeguarding users and ensuring the market's integrity. The organization remains committed to eradicating fraudulent behaviors and enhancing compliance...

Continue Reading
Market Insights: Asian Shares and Economic Influences

Updated Category News Views 154

Mixed Outcomes in Asian Markets Asian shares displayed a blend of positive and negative trends as markets reacted to the recent surge in U.S. stocks, which reached new peaks to end a successful trading week. U.S. futures reflected this mixed sentiment, while oil prices experienced an upward trend. Performance of Key Indices In Hong Kong, the Hang Seng index dropped 1.5%...

Continue Reading
Understanding Recent CPSC Recalls and Safety Measures

Updated Category News Views 280

Understanding Recent CPSC Recalls and Safety Measures The Consumer Product Safety Commission (CPSC) plays a crucial role in safeguarding the public from hazards associated with consumer products. Recently, several recalls have been announced to protect consumers from potential risks. These recalls, conducted in cooperation with various firms, aim to address safety...

Continue Reading
Significant Advancements in Lymphedema Treatment Using Flexitouch® Plus

Updated Category News Views 213

Groundbreaking Results from Flexitouch® Plus Study In an exciting development for medical technology, Tactile Systems Technology, Inc. (Nasdaq: TCMD) has presented remarkable findings from a recent late-breaking poster session at a prominent rehabilitation medicine conference. The data highlights the sustained clinical benefits of Flexitouch® Plus as a primary therapy...

Continue Reading